UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment
With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
dapirolizumab pegol
UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment
With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…